Roche aims for de­risked deals and ruth­less port­fo­lio cuts in 2025

Roche’s M&A strat­e­gy in the com­ing year re­volves around de­risked mech­a­nisms and high un­met needs, CEO Thomas Schi­neck­er said Thurs­day. And fur­ther deal­mak­ing over as­sets …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER